Unique Organics (530997)

Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Let's examine Unique Organics through a value investor's lens. A P/E of 8.12 and a 21.95% ROE initially look tempting, and a ROCE over 50% suggests efficient capital use. But Graham warned us to dig beneath the surface. Sales collapsed by 71.24%, yet profit fell only 34.77% — that means margins expanded dramatically. In the latest quarter, ₹17 Cr of sales produced ₹2 Cr net profit, implying a ~12% margin. I ask myself: is this a fundamentally improved business or a one-off lucky quarter? The Piotroski F-Score of 3/9 screams financial stress, and the absence of any dividend means I rely solely on price appreciation. With no promoter holding data and a market cap of just ₹61 Cr, this is a thinly traded micro-cap. I also see book value of ₹50.52, so I'm paying ₹101.97 — roughly 2 times tangible assets — for a commodity-linked agricultural business with no clear moat. The 52-week range of ₹65 to ₹127.50 shows how volatile this stock can be. Could it be a turnaround? Perhaps. But as Buffett says, 'Turnarounds seldom turn.' I'd need to understand why sales fell so sharply and whether the current earnings are repeatable. For now, this is a possible cyclical or event-driven play, not a predictable compounding machine. I'd wait for more stable revenue and better financial health signals before committing capital.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer